<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0020177"><a href="http://purl.obolibrary.org/obo/MONDO_0020177">MONDO:0020177</a></h3>
<p><strong>Label:</strong> pigmented palpebral tumor</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0020178">MONDO:0020178</a> (palpebral lentiginosis), <a href="http://purl.obolibrary.org/obo/MONDO_0020179">MONDO:0020179</a> (palpebral nevus), <a href="http://purl.obolibrary.org/obo/MONDO_0018961">MONDO:0018961</a> (familial melanoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015285">MONDO:0015285</a> (Carney complex), <a href="http://purl.obolibrary.org/obo/MONDO_0008280">MONDO:0008280</a> (Peutz-Jeghers syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0007893">MONDO:0007893</a> (Noonan syndrome with multiple lentigines),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_608837">OMIM:608837</a>, <a href="http://purl.obolibrary.org/obo/OMIM_160980">OMIM:160980</a>, <a href="http://purl.obolibrary.org/obo/OMIM_155601">OMIM:155601</a>, <a href="http://purl.obolibrary.org/obo/OMIM_155700">OMIM:155700</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151100">OMIM:151100</a>, <a href="http://purl.obolibrary.org/obo/OMIM_155600">OMIM:155600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613099">OMIM:613099</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615134">OMIM:615134</a>, <a href="http://www.orpha.net/ORDO/Orphanet_618">Orphanet:618</a>, <a href="http://purl.obolibrary.org/obo/OMIM_175200">OMIM:175200</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613972">OMIM:613972</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2869">Orphanet:2869</a>, <a href="http://purl.obolibrary.org/obo/OMIM_611554">OMIM:611554</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615848">OMIM:615848</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608035">OMIM:608035</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609048">OMIM:609048</a>, <a href="http://purl.obolibrary.org/obo/OMIM_605244">OMIM:605244</a>, <a href="http://www.orpha.net/ORDO/Orphanet_500">Orphanet:500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_1359">Orphanet:1359</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98587">Orphanet:98587</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98588">Orphanet:98588</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613707">OMIM:613707</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004328">HP:0004328</a> (Abnormality of the anterior segment of the globe))) 47.60%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology))) 46.37%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002860">HP:0002860</a> (Squamous cell carcinoma))) 46.37%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000708">HP:0000708</a> (Behavioral abnormality))) 46.37%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision))) 46.37%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0030669">HP:0030669</a> (Abnormal morphology of the ocular adnexa))) 45.26%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0006739">HP:0006739</a> (Squamous cell carcinoma of the skin))) 45.26%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis))) 45.26%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000613">HP:0000613</a> (Photophobia))) 44.25%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000492">HP:0000492</a> (Abnormality of the eyelid))) 44.25%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001034">HP:0001034</a> (Hypermelanotic macule) and <a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system) 43.34%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma))) 43.34%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003764">HP:0003764</a> (Nevus) and <a href="http://purl.obolibrary.org/obo/HP_0011792">HP:0011792</a> (Neoplasm by histology) 42.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002861">HP:0002861</a> (Melanoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000621">HP:0000621</a> (Entropion))) 42.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0003764">HP:0003764</a> (Nevus) 41.85%</li>
</ul>
</body>
</html>
